10X Capital Venture Acquisition Corp. III
VCXBDelisted Jul 26, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001848948
10X Capital Venture Acquisition Corp. III was delisted on Jul 26, 2024; its insiders filed their last Form 4 on Mar 11, 2022; 11 institutions reported holding it in 13F filings for Q2 2024, worth $21.4M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding 10X Capital Venture Acquisition Corp. III changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 53 | 56 | +3 |
| Shares | 23.7M | 24.4M | +745.6K (+3.1%) |
| Value | $236.5M | $246.6M | +$10.2M (+4.3%) |
New holders (8)
Institutions that held 10X Capital Venture Acquisition Corp. III at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mizuho Markets Americas LLC | 1,106,692 | $11.2M | 0.51% |
| Anson Funds Management LP | 100,000 | $1.01M | 0.19% |
| Whitebox Advisors LLC | 50,000 | $505.0K | 0.01% |
| Vivaldi Asset Management, LLC | 45,000 | $455.0K | 0.02% |
| Bank of Montreal | 40,000 | $404.0K | 0.00% |
| Virtu Financial LLC | 10,870 | $110.0K | 0.01% |
| Elequin Capital LP | 500 | $5.00K | 0.00% |
| Clear Street LLC | 100 | $1.00K | 0.00% |
Sold out (5)
Institutions that held 10X Capital Venture Acquisition Corp. III at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Woodline Partners LP | 175,000 | $1.75M |
| Fifth Lane Capital, LP | 80,360 | $804.0K |
| Union Square Park Capital Management, LLC | 50,000 | $500.0K |
| Eisler Capital (UK) Ltd. | 29,908 | $299.0K |
| Cohen & Co Financial Management, LLC | 34,999 | $3.00K |